Next Article in Journal
Dynamic Structure of Yeast Septin by Fast Fluctuation-Enhanced Structured Illumination Microscopy
Next Article in Special Issue
Common Features and Intra-Species Variation of Cutibacterium modestum Strains, and Emended Description of the Species
Previous Article in Journal
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
Previous Article in Special Issue
Comparative Pan-Genome Analysis of Oral Veillonella Species
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 9
Issue 11
10.3390/microorganisms9112254
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota

by
Isaiah Song
1,
Yasuhiro Gotoh
2,
Yoshitoshi Ogura
3,
Tetsuya Hayashi
2,
Satoru Fukiya
1,* and
Atsushi Yokota
1
1
Laboratory of Microbial Physiology, Research Faculty of Agriculture, Hokkaido University, Sapporo 060-8589, Japan
2
Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
3
Department of Infectious Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan
*
Author to whom correspondence should be addressed.
Microorganisms 2021, 9(11), 2254; https://doi.org/10.3390/microorganisms9112254
Submission received: 24 September 2021 / Revised: 22 October 2021 / Accepted: 22 October 2021 / Published: 29 October 2021
(This article belongs to the Special Issue New Anaerobic Bacteria in Human Health and Disease)
Browse Figures
Versions Notes

Abstract

:
The human gut houses bile acid 7α-dehydroxylating bacteria that produce secondary bile acids such as deoxycholic acid (DCA) from host-derived bile acids through enzymes encoded by the bai operon. While recent metagenomic studies suggest that these bacteria are highly diverse and abundant, very few DCA producers have been identified. Here, we investigated the physiology and determined the complete genome sequence of Eubacterium sp. c-25, a DCA producer that was isolated from human feces in the 1980s. Culture experiments showed a preference for neutral to slightly alkaline pH in both growth and DCA production. Genomic analyses revealed that c-25 is phylogenetically distinct from known DCA producers and possesses a multi-cluster arrangement of predicted bile-acid inducible (bai) genes that is considerably different from the typical bai operon structure. This arrangement is also found in other intestinal bacterial species, possibly indicative of unconfirmed 7α-dehydroxylation capabilities. Functionality of the predicted bai genes was supported by the induced expression of baiB, baiCD, and baiH in the presence of cholic acid substrate. Taken together, Eubacterium sp. c-25 is an atypical DCA producer with a novel bai gene cluster structure that may represent an unexplored genotype of DCA producers in the human gut.

1. Introduction

Bile acids are cholesterol-derived compounds that are synthesized as primary bile acids by the liver and secreted into the gastrointestinal tract to aid in digestion of fat-soluble nutrients following a meal [1,2]. These primary bile acids circulate between the liver and gastrointestinal tract in a process known as enterohepatic circulation, with about 95% actively reabsorbed into circulation upon reaching the terminal ileum [3]. However, the remaining 5% continue into the colon and are subjected to gut microbiota-mediated biotransformation, including 7α/β-dehydroxylation of primary bile acids into what are known as secondary bile acids [2,3]. The two most abundant primary bile acids in humans are cholic acid (CA; 3α,7α,12α-trihydroxy-5β-cholan-24-oic acid) and chenodeoxycholic acid (CDCA; 3α,7α-dihydroxy-5β-cholan-24-oic acid), which are metabolized into the secondary bile acids deoxycholic acid (DCA; 3α,12α-dihydroxy-5β-cholan-24-oic acid) and lithocholic acid (3α-hydroxy-5β-cholan-24-oic acid), respectively. DCA is the most prevalent bile acid found in human fecal and cecal samples, making up roughly 34% of bile acids in both [3,4]. This is attributed to efficient passive reabsorption of DCA into the circulating bile acid pool due to its increased lipophilicity [5] as well as the human body’s inability to 7α-hydroxylate DCA back into its primary bile acid configuration. DCA has long been implicated in health issues such as liver and colon carcinogenesis [6,7,8,9] and cholesterol gallstone disease [10,11], but it has also been observed to enhance resistance to Clostridioides difficile colonization [12] and even suppress tumorigenesis in gallbladder cancer [13]. The holistic impact of DCA on human health and host-microbe interplay is not well-understood but warrants further investigation due to its biomedical importance.
7α-dehydroxylating bacteria possess a cluster of bile-acid inducible (bai) genes responsible for 7α-dehydroxylation of primary bile acids [3]. The core genes (baiA2-I) each encode a necessary enzyme in the multi-step 7α-dehydroxylation pathway and form a single operon [14] (Figure 1). While substantial amounts of DCA are produced solely by microbial biotransformation [3], the currently known DCA producers consist of a very small number of species belonging to the genus Clostridium and other closely related genera [2,15]. Their actual population numbers and diversity are unknown. It is estimated that the 7α-dehydroxylating pathway exists only in about 0.0001% of the colonic microbiota [3]. However, a recent large-scale analysis of public metagenome-assembled genome data suggests that up to almost 1% of intestinal bacteria may possess bai genes, and that these strains are taxonomically diverse [16,17]. In another study, a fecal cell count of Clostridium scindens [18], a DCA producer known to possess high 7α-dehydroxylation activity relative to other known DCA producers [19], revealed very low cell numbers (105.5 cells/g of feces) and no significant correlation between C. scindens abundance and DCA levels in healthy Japanese subjects [20]. It is therefore necessary to further investigate the existence of other 7α-dehydroxylating bacteria and understand to what extent they contribute to DCA formation in humans.
In the early 1980s, Dr. Hirano’s laboratory published their discovery of 13 new 7α-dehydroxylating strains isolated from healthy adult fecal samples and wastewater [21]. Of these, three strains from adult fecal samples were not readily identifiable as Clostridium species, including a non-sporulating, Gram-positive “Eubacterium lentum-like” strain, “c-25” [21,22] (referred to as Eubacterium sp. c-25 in our study). This strain demonstrated the ability to 7α-dehydroxylate both CA and CDCA in vitro [21,22]. While the physiology and bile acid metabolism of c-25 were studied to an extent over the course of several years following its discovery [21,22,23,24,25], there are no recent reports studying this strain, and current mentions of the strain are almost nonexistent. As such, c-25 is poorly understood, especially in the context of our present-day knowledge of secondary bile acid metabolism. The lack of genomic and taxonomic information also limits our ability to compare the strain to other intestinal DCA producers.
The aim of this study was to expand upon our understanding of the previously described physiology of c-25 by gathering additional data supported by genomic information. As c-25 reportedly lacked the characteristic traits of Clostridium species [21], we believed it could be a taxonomically distinct, non-Clostridium intestinal DCA producer. We ran comparative tests of c-25 with two strains of C. scindens, a species which has been studied extensively as a representative intestinal DCA producer for years [3,18,26,27] and thus served as a baseline for our studies. The C. scindens strains used were: ATCC 35704T [26,28] and G10, a rat cecal strain isolated in our previous study [29]. For our investigation, emphasis was placed on the conditions necessary for optimal growth and DCA production and the genetic differences between c-25 and other DCA producers, including genome-based phylogeny and expression of the bai gene cluster. Taken together, these data also give insight into intestinal conditions conducive for DCA formation, the unexplored diversity of DCA producers, and the genetic basis for 7α-dehydroxylation.

2. Materials and Methods

2.1. Bile Acids

The bile acids used in this study were purchased from the following companies: sodium salts of CA and DCA, Merck Sigma-Aldrich (Darmstadt, Germany); 7-oxo-deoxycholic acid (7-oxo-DCA; 3α,12α-dihydroxy-7-oxo-5β-cholan-24-oic acid), Steraloids, Inc. (Newport, RI, USA).

2.2. Bacterial Strains and Culture Conditions

Eubacterium sp. c-25 was kindly provided by Dr. Hiroshi Oda (Department of Bacteriology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan) for our previous study [30]. Clostridium scindens ATCC 35704T was provided by the RIKEN BRC through the National BioResource Project of the MEXT/AMED, Japan, under the name Clostridium scindens JCM 6567T, and Clostridium scindens G10 was isolated in our laboratory (Microbial Physiology, Hokkaido University) from rat cecal contents [29]. All strains were stored at −80 °C in 25% glycerol solution and were cultured anaerobically in Gifu Anaerobic Medium (GAM; Nissui Pharmaceutical Co. Ltd., Tokyo, Japan) at 37 °C. Freshly prepared GAM has an initial pH of approximately 7 and any necessary pH adjustments (i.e., pH 6, 8, and 9) were made using HCl or NaOH prior to autoclave sterilization. Dissolved oxygen was removed by leaving medium in a sealed pouch overnight with AnaeroPack oxygen-removal catalysts (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan). Initial pre-cultures were prepared by directly inoculating tubes of liquid GAM with cells from frozen stock cultures and incubating in an anaerobic chamber (Coy Laboratory Products Inc., Grass Lake, MI, USA) partially unsealed. Bacterial growth was measured as optical density at 660 nm (OD660) using the UV-1800 spectrophotometer (Shimadzu Corp., Kyoto, Japan). The initial pre-cultures were sub-cultured a minimum of one time, with the inoculum volume adjusted for an initial OD660 of 0.05 in subsequent cultures. All sub-cultures were prepared using source cultures at late-exponential to early stationary growth phase. Test cultures were incubated in butyl rubber-sealed Hungate screw-cap tubes in a 37 °C water bath after flushing the headspace with an anoxic gas mixture through the rubber stopper via 25G syringe tip. The same gas composition of N2, CO2, and H2 (8:1:1) was used for both the culture headspace and anaerobic chamber atmosphere. Bacterial growth in the test cultures was measured by OD660 using the SPECTRONIC 20D+ spectrophotometer (Thermo Spectronic, Rochester, NY, USA) over a period of 48 h. Bile acids were not added to pre-cultures, while test cultures were supplemented with CA to a concentration of 0.1 mM. As DCA was shown to have a strong inhibitory effect on tested secondary bile acid producers (data not shown), the initial CA substrate was limited to 0.1 mM to minimize this effect.

2.3. Quantification of Bile Acids in Bacterial Cultures by UPLC-ESI-MS/MS

For analysis of bile acid content in bacterial cultures, 100 µL of culture medium was collected per time point using syringes flushed with filter-sterilized anoxic gas. Samples were acidified with 20 µL of 3N HCl and stored at −30 °C until use. Five volumes of ethyl acetate were added to the acidified samples, which were then vortexed for 1 min and centrifuged at 18,000× g for 5 min to induce phase separation. The upper phase was collected and dried by centrifugal evaporation, re-suspended in methanol, and purified by gravity flow through Oasis HLB 1cc extraction cartridges (Waters Corp., Milford, MA, USA). Bile acids were eluted in 1 mL methanol, dried by centrifugal evaporation, and stored at −30 °C until further analysis.
To quantify the bile acids, the dried, purified samples were re-suspended in 1 mL of methanol, from which 200 µL was taken for bile acid quantification using the ACQUITY UPLC System (Waters Corp.) and Quattro Premier XE Mass Spectrometer (Waters Corp.) using an analytical method described in the literature [31] modified for one of our previous studies [29]. An ACQUITY UPLC BEH C18 column (Waters Corp.) was used for sample separation. Solvents A (80% (v/v) acetonitrile solution containing 10 mM ammonium acetate) and B (20% acetonitrile (v/v) solution containing 10 mM ammonium acetate) were used in a 2-minute, 50:50 isocratic flow method with a flow rate of 0.4 mL/min to separate CA, DCA, and 7-oxo-DCA, which were then quantified through selected ion recording. The m/z values scanned were 407.57 for trihydroxylated bile acids (CA), 391.60 for dihydroxylated bile acids (DCA), and 405.56 for dihydroxylated, mono-oxo-bile acids (7-oxo-DCA).
CA, DCA, and 7-oxo-DCA concentrations were calculated from the raw chromatogram data by comparison of peak area against standard curves of each bile acid constructed from two-fold serial dilutions within a concentration range of 0.195–6.25 μM. The concentrations were added together and interpreted as the total bile acid pool. Percent composition was then calculated based on the proportion of each bile acid relative to the total concentration of CA, DCA, and 7-oxo-DCA.

2.4. Scanning Electron Microscopy (SEM) Imaging

Eubacterium sp. c-25 cultures were grown in 8 mL of GAM for 6, 12, and 24 h, associated with mid-exponential, late-exponential, and stationary growth phase, respectively. Cells were harvested by centrifugation at 18,000× g for 5 min, washed with phosphate-buffered saline (PBS; 20 mM potassium phosphate buffer, 0.85% (w/v) NaCl, pH 7.4), and fixed onto a glass slide coated with poly-L-lysine with 2.5% (v/v) glutaraldehyde (TAAB Laboratories Equipment Ltd., Berkshire, UK) in PBS for one hour at room temperature. Slides were then washed with PBS and subjected to a secondary fixation step with 2% (v/v) osmium tetroxide in PBS for 30 min, again at room temperature. Following fixation, the cells were dehydrated by washing with a graded series of ethanol solutions (50%, 70%, 90%, 99.5% v/v) for 10 min intervals, with the highest concentration ethanol wash performed twice. The cells were then dried by critical point drying using liquid carbon dioxide (EM CPD300; Leica Microsystems, Wetzlar, Germany) and subsequently coated with a 12-nm layer of Au-Pd via ion sputtering (MSP-20-MT; Vacuum Device, Mito, Japan). Samples were visualized by scanning electron microscope (JSM-6301F; JEOL Ltd., Tokyo, Japan) at an acceleration voltage of 5 kV.

2.5. Complete Genome Sequencing of Eubacterium sp. c-25 and C. scindens G10

The genome sequences of Eubacterium sp. c-25 and C. scindens G10 were determined using a combination of Illumina MiSeq (Illumina, Inc., San Diego, CA, USA) and Nanopore MinION (Oxford Nanopore Technologies, Ltd., Oxford, UK) sequencing. For the first set of sequence data, Eubacterium sp. c-25 and C. scindens G10 genomic DNA (gDNA) was extracted from harvested cells from cultures grown in an anaerobic chamber until stationary phase. Using a previously described method [32], cells were subjected to enzymatic cell wall digestion by lysozyme at a final concentration of 15 mg/mL (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan) and DNA extraction using the Isoplant II kit (Nippon Gene Co., Ltd., Tokyo, Japan). All gDNA extractions in this study were followed by quantification with the Qubit 3.0 Fluorometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Short-read sequencing libraries were prepared with the NEBNext Ultra II FS DNA library preparation kit for Illumina (New England Biolabs, Inc., Ipswich, MA, USA) and then sequenced using Illumina MiSeq to obtain 301 bp paired-end reads.
High-molecular weight gDNA for Nanopore MinION sequencing was extracted from harvested Eubacterium sp. c-25 and C. scindens G10 cells in stationary phase by first subjecting them to enzymatic cell wall digestion at 37 °C with lysozyme (15 mg/mL, final concentration) for one hour followed by achromopeptidase (3 mg/mL, final concentration; FUJIFILM Wako Pure Chemical Corp.) for 30 min. This was followed by overnight incubation with Proteinase K (QIAGEN, Hilden, Germany) at 37 °C. The lysed samples were then treated with Tris-EDTA (TE)-saturated phenol and PCI (phenol, chloroform, and isoamyl alcohol at a 25:24:1 ratio) and stored overnight at 4 °C after RNase A (Nippon Gene) addition. Further purification was conducted using the Genomic-tip 20/G (QIAGEN) as per manufacturer’s instructions, with the exception of replacing vortex steps with gentle tube inversions to prevent shearing of gDNA. Long-read sequencing libraries were prepared with the Rapid Barcoding Kit (SQK-RBK004; Oxford Nanopore Technologies, Ltd.), sequenced using an R9.4.1 flow cell on the Oxford Nanopore MinION (Oxford Nanopore Technologies, Ltd.), and basecalled using Guppy GPU v3.4.5 (Oxford Nanopore Technologies, Ltd.).
Hybrid assembly of Illumina MiSeq and Nanopore MinION genome sequence data was conducted using Unicycler v0.4.7 [33,34]. Assembled genomes were then annotated using the DFAST pipeline [35], run in parallel with Prodigal [36] for structural annotation. The closed Eubacterium sp. c-25 and C. scindens G10 genomes were submitted to DDBJ under the accession numbers AP024845 and AP024846, respectively.

2.6. Bioinformatics Analyses

To identify phylogenetic relatives of Eubacterium sp. c-25, a BLASTn search for the c-25 16S rDNA sequence was conducted against the NCBI non-redundant Nucleotide database. Additionally, local BLASTn analysis of 16S rDNA sequence similarity across known DCA producers and other relevant strains was performed using GENETYX Ver.12 (Genetyx Corp., Tokyo, Japan). A Maximum Likelihood phylogenetic tree based on 16S rDNA sequences aligned using ClustalW [37] was constructed in MEGA X [38] using the Tamura–Nei model [39]. Robustness was assessed using 1000 bootstraps and other settings were left at default. Species-level taxonomic delineation was conducted by calculating average nucleotide identity (ANI) between genomes using the Orthologous Average Nucleotide Identity Tool (OAT) [40]. Information on all genomes used for bioinformatics analyses is listed in Table 1. OrthoFinder [41,42] was used to identify probable bai genes in Eubacterium sp. c-25 and in other potential secondary bile acid producers by virtue of its genome-wide orthologue inference algorithm. Identifiers for all predicted bai genes are listed in Table S1.
For comparative analysis of bai genes, local BLASTp was conducted using GENETYX Ver.12 to compare amino acid sequence similarity of bai gene products. Genomic locations of bai genes were determined using the genome visualization tool Artemis [43]. Promoter prediction within the bai gene cluster was performed using the BPROM program [44] offered by Softberry (http://www.softberry.com/; accessed on 7 September 2021).
In order to search for strains that could share a similar arrangement of bai genes with c-25, a Microbial Protein BLASTp search was conducted using c-25’s baiB protein sequence. The genomes of cultured and isolated strains possessing a candidate protein above a percent sequence identity threshold of 70% were acquired for further analyses. The metabolic gene cluster identification pipeline gutSMASH [45] was used to detect the presence of the bai operon in the candidate strains and perform preliminary arrangement prediction based on reference metabolic gene cluster databases.

2.7. Measurement of bai Gene Expression Using qRT-PCR

Expression of potential bai genes identified in Eubacterium sp. c-25 and C. scindens G10 was measured using real-time quantitative reverse transcription PCR (qRT-PCR) on the StepOnePlus Real-Time PCR System (Applied Biosystems, Waltham, MA, USA). Based on the structure of the predicted bai gene cluster in c-25, three genes were selected for measurement: baiB, baiCD, and baiH. Primers were constructed using the web-based Primer-BLAST [46] tool at default settings with strain-specific genomes as custom databases. Primer sequences are detailed in Table S2. All bacterial cultures were grown in GAM (pH 8) with or without 0.1 mM CA and sampled for analysis after 8 h of growth. Samples were washed with saline (0.85% [w/v] NaCl) and treated with RNAprotect Bacterial Reagent (QIAGEN), pelleted, and immediately frozen with liquid nitrogen for storage at −80 °C. Total RNA was extracted using a combination of enzymatic cell wall digestion and mechanical cell disruption as described in a separate study [47]. Synthesis of cDNA and analysis using qRT-PCR were also performed according to the methods and parameters outlined in the aforementioned study [47]. Gene expression was measured using the standard curve method, in which expression levels of reference housekeeping gene recA in serially diluted samples were used as a baseline for determining relative expression of the genes of interest, as conducted in the bai gene expression analysis in C. scindens ATCC 35704T [26].

2.8. Statistical Tests

All statistical tests were conducted using R [48]. qRT-PCR data was first subjected to equal variance testing, and was analyzed using Welch’s t-test if the equal variance testing was significant (p < 0.05). Otherwise, the data was analyzed using Student’s t-test. All t-tests were one-tailed, as bai gene expression was expected to increase in G10 and c-25, as reported in C. scindens in the presence of CA [26]. In this context, we would interpret a decrease in expression as the practical equivalent of no significant increase, as either result is a strong indicator that the products of the genes in question are not directly involved in 7α-dehydroxylation.

3. Results

3.1. Morphology

Cells from 6 h c-25 cultures, corresponding to mid-exponential growth phase, were harvested for SEM visualization. In a previous report, c-25 was observed to exist either as single, bacillus-shaped cells or in short chains of two to three cells [21]. However, we observed that c-25 cells formed long, end-to-end linked, non-branching filaments, with the single-cell morphology being exceedingly rare (Figure 2). Due to these structural traits, cell boundaries were sometimes difficult to delineate. Most segments were 1–2 µm in length, with some rare outliers reaching up to 8 µm.
Laterally arranged surface structures were found on virtually every cell, often forming a ring-like pattern (Figure 2a, arrows). Flagella and cillia were not visible. Large, roughly spherical structures were also found at the terminal ends of some cell chains (Figure 2c, arrow).
There were no noticeable differences in c-25 morphology in cells observed at 12 h (Figure 2c) and 24 h (not shown) time points corresponding to late-exponential and stationary growth phase, respectively.

3.2. Growth and Bile Acid Profile

The growth and DCA production of Eubacterium sp. c-25 were compared to C. scindens strains G10 and ATCC 35704T in a series of culturing experiments. A point of interest is the ability of c-25 to grow and produce DCA in various pH conditions, as studies show that gastrointestinal pH is highly variable along the length of the intestines and is influenced by various physiological factors [49,50,51]. The composition of microbiotal communities is known to differ by gastrointestinal region based on the physiochemical properties of the local environment [52]. Additionally, the optimal pH for 7α-dehydroxylation enzymatic activity reported in early studies using washed whole cells was 7.3–7.7 for c-25 [22] and 7.0 for C. scindens strain VPI 12708 [53], warranting investigation into the effects of pH on DCA production in metabolically active in vitro cultures over time. To this end, medium pH was adjusted to an initial pH of 6, 7, 8, or 9 (±0.15) and pre-cultures that were grown at pH 7 were used for inoculation. Growth and bile acid production profile were measured over 48 h. The medium was not buffered because preliminary data showed noticeable decreases in the growth of c-25 when in the presence of several tested organic buffers (data not shown). For this reason, medium pH adjustment resulted in a transient initial pH that slowly decreased over time due to a combination of carbonic acid formation from aqueous carbon dioxide and acidic bacterial metabolites. Initial and final medium pH values were measured in each culture and can be found in Table S3.
The bile acids analyzed in each sample were CA, DCA, and 7-oxo-DCA, because these were the only bile acids detected during initial bile acid screening of CA-supplemented c-25 cultures against a panel of 31 bile acids (data not shown). 7-oxo-DCA is formed from CA through a reversible reaction catalyzed by 7α-hydroxysteroid dehydrogenases [3]. Accordingly, CA, DCA, and 7-oxo-DCA were interpreted as the total quantitatively relevant bile acid pool associated with CA metabolism.
Known DCA producers have been reported to possess varying degrees of 7α-dehydroxylation capabilities, with C. scindens exhibiting particularly high activity up to ~100-fold higher than other strains [19]. The results of our tests appear to be consistent with these reports (Figure 3a–h). The highest peak growth, along with the most rapid increase in DCA and decrease in CA, was observed at pH 7 and 8 in both G10 and ATCC 35704T. In these two pH conditions, relative levels of CA dropped rapidly within 2–6 h of incubation, coinciding with early to mid-exponential growth phase. This drop was accompanied by a proportionate increase in DCA, which plateaued at about 80–90% of the bile acid pool. 7-oxo-DCA was observed at a constant 5–10% of the bile acid pool following the initial spike in DCA. While growth and DCA formation were also observed at pH 6 and 9, the rate of growth was lower and CA-to-DCA conversion was delayed. Interestingly, DCA formation was more favorable at pH 9 than 6 for G10, while the opposite was true for ATCC 35704T. DCA formation was not inexorably linked to cell density, as pH 6 cultures of both C. scindens strains exhibited considerably high DCA formation at low OD660 in the early stages of growth. Overall, the detection of both DCA and 7-oxo-DCA, in conjunction with the near-complete removal of CA, confirmed 7α-dehydroxylation and 7α-hydroxysteroid dehydrogenase activity, respectively, in both strains.
The c-25 cultures showed a much lower OD660 across all conditions, peaking at 0.374 compared to 1.310 and 1.133 for G10 and ATCC 35704T, respectively, (Figure 3i–l). The strain exhibited the most rapid growth and highest peak OD660 at pH 8. The bile acid profile of c-25 showed a steady decrease in CA with a corresponding increase in DCA and 7-oxo-DCA over the course of 48 h at pH 7 and 8. However, the conversion rate was much slower than that of the C. scindens strains, with approximately 70–80% of the CA substrate metabolized by 36 h. The pH 8 condition showed the highest amount of DCA formation, with DCA levels continuing to increase to almost 50% after 36 to 48 h of incubation. Notably, the total bile acid pool also consisted of much higher proportions of 7-oxo-DCA than in the C. scindens strains at both pH 7 and 8. This was especially noticeable at pH 7, at which 7-oxo-DCA levels surpassed that of DCA by 36 h. Interestingly, there were no signs of growth or CA conversion at pH 6. At pH 9, although cultures showed clear growth, no DCA production was observed and the only evidence of bile acid transformation was of 7-oxo-DCA formation after 12 h.
In terms of optimal growth conditions, C. scindens ATCC 35704T, C. scindens G10, and Eubacterium sp. c-25 appeared to prefer neutral to slightly alkaline conditions, i.e., pH 7 and 8. These were also the conditions that induced the most rapid production of DCA. However, the ability of a DCA producer to 7α-dehydroxylate CA appears to be separate from its ability to grow and proliferate. As shown for the pH 6 and 9 cultures of G10 and ATCC 35704T (Figure 3a,d,e,h), cell density and DCA production are not directly correlated, possibly due to differences in enzymatic activity or induced bai gene expression. This is especially evident in c-25, which exhibited higher DCA formation at pH 8 than 7, but no DCA was detected at pH 9 though moderate growth was observed (Figure 3j–l).

3.3. Complete Genome Sequencing and Strain Identification

For proper taxonomic identification of c-25 based on phylogenetic analyses using genome sequence information, the complete genome sequence of c-25 was determined along with that of C. scindens G10, which also lacked genomic information and would be used in comparative genomic analyses with c-25 (Table 2). Using the newly acquired genomic data, a BLASTn search for the c-25 16S rDNA sequence was conducted to search for closely related species. Interestingly, the closest match was Lachnoclostridium phocaeense, a bacterium isolated from human urine [54], at 97.2% sequence identity.
While this was already below proposed species delineation thresholds of ~98–99% [55,56], ANI analyses were additionally conducted to differentiate c-25 from L. phocaeense with more certainty (Figure 4). With results showing only 74.9% ANI, far from the generally accepted 95% intra-species cutoff [57,58], we concluded that c-25 is not the same species as L. phocaeense. Moreover, even lower ANI values (64.65% to 71.82%) were observed against the other DCA producers listed in Table 1, demonstrating the phylogenetic uniqueness of c-25 amongst them, at least at the species level. C. scindens G10 also displayed similar ANI values to other DCA producers (64.66% to 73.75%) but showed a 99.35% match with C. scindens ATCC 35704T, confirming its identity as a strain of C. scindens.
To study the phylogeny and higher-level taxonomy of c-25, a phylogenetic tree was constructed using the top-29 BLASTn hits against the 16S rDNA sequence from c-25, along with those from additional DCA producers: C. scindens ATCC 35704T, C. scindens G10, and Peptacetobacter hiranonis (Figure 5). We only included strains with an established or proposed species-level taxonomic designation according to the NCBI Taxonomy Database. Interestingly, C. hylemonae was the only DCA producer that appeared within the top 29 hits. The tree also included newly hypothesized DCA producers that were identified later in the study: Sporofaciens musculi, Dorea sp. AM58-8, and Dorea sp. AF36-15AT (Table 1). Finally, because c-25 was most closely related to L. phocaeense according to 16S rDNA similarity but no other Lachnoclostridum strains were detected within the top BLAST hits, we also added three additional Lachnoclostridium strains to predict whether c-25 could be a member of the genus Lachnoclostridium by virtue of its phylogenetic distance to other members of this genus: Lachnoclostridium edouardi Marseille-P3397 (NZ_OESQ01000006), Lachnoclostridium pacaense Marseille-P3100 (NZ_LS999944), and Lachnoclostridium phytofermentans ISDg (NC_010001). Thus, a total of 39 strains were included in the phylogenetic tree (Figure 5).
The results indicated that Eubacterium sp. c-25 is most closely related to L. phocaeense and is distant from other known DCA producers such as C. scindens, C. hylemonae, and P. hiranonis. Unexpectedly, however, the other close relatives do not include additional Lachnoclostridium species, but members of the genera Drancourtella, Massilistercora, and Mordavella in the order Eubacteriales. Furthermore, other Lachnoclostridium species are also not clustered together as would be expected from members of the same genus. These findings indicated that Eubacterium sp. c-25 is likely a member of the order Eubacteriales but correct classification at family and genus level is not possible due to the ambiguous taxonomic status of the genus Lachnoclostridium [59]. Re-examination of their taxonomy and valid publication of taxa names are required, including that of L. phocaeense, to obtain reliable taxonomic information on c-25.

3.4. Identification of bai Genes

Genome-wide categorization of orthologous genes from c-25 and the other DCA producers using OrthoFinder allowed for the discovery of a set of genes that were predicted to be orthologues of C. scindens ATCC 35704T bai genes (Supplementary File S1) in both c-25 (EUBC25_24880–EUBC25_24960, EUBC25_02220) and G10 (CSCING10_002180–CSCING10_002270). The protein sequence similarities of predicted c-25 Bai proteins to those of C. scindens ATCC 35704T were surprisingly low with the exception of BaiH (Figure 6). A local BLASTp search confirmed that no other proteins encoded in the c-25 genome share greater sequence similarity to C. scindens ATCC 35704T Bai proteins than those identified by OrthoFinder, lending support to their predicted identity as bai gene orthologues.
Gene arrangement of the hypothesized c-25 bai genes was found to be very different from that of C. scindens (Figure 7). Unlike in C. scindens where the entire bai gene cluster is controlled by a single promoter and produces a single polycistronic mRNA [60,61], it appears that the bai genes of c-25 are separated into multiple gene clusters that are presumably transcribed from different promoter sites (see Table S4 for promoter prediction information). In c-25, baiA2BGF and baiCDE each constitute a gene cluster, while baiH and baiI do not share a promoter with other bai genes. The genes encoding predicted bile acid-regulatory elements (barA, barB) proposed to be involved in transcriptional regulation [3] were found upstream of the baiA2BGF cluster. In addition, baiI is located in a separate chromosomal region far from the rest of the bai genes. Importantly, a baiG orthologue was not identified in c-25. Instead, a gene encoding a major facilitator superfamily (MFS) transporter similar to the C. scindens BaiG transporter existed downstream from baiB, though amino acid sequence identity was low (22%, E-value 0.013, BLASTp). We hypothesize that this BaiG-like transporter is a functional homologue of baiG.
The same analyses were also performed on the genome of C. scindens G10. These analyses identified a bai operon structure nearly identical to that of C. scindens ATCC 35704T (same gene arrangement as in Figure 1b and ~100% amino acid sequence identity of Bai proteins), as expected of members of the same species. The results confirm that C. scindens G10 is included as a conventional 7α-dehydroxylating species both in DCA production profile and the genomic basis for its 7α-dehydroxylation ability.

3.5. Expression Analysis of bai Genes in the Presence of CA

As the bai gene candidates were successfully identified in Eubacterium sp. c-25, we performed qRT-PCR analysis with specific primers for baiB, baiCD, and baiH. The aims of this analysis were to verify the identity of the hypothetical bai genes by testing induced expression levels in the presence of CA as observed in C. scindens [26] and to compare the expression levels of each gene with those in C. scindens G10. It is worth noting that bai genes in C. scindens ATCC 35704T were shown to be transcribed at a basal level in the absence of CA and could moreover be downregulated to an even lower level of expression [26]. We expected that relative gene expression levels of baiB, baiCD, and baiH would be similar in G10, in which they are transcribed from a single promoter site, while their equivalents in c-25 would show more variance. These bai genes were selected because they are representative of the three main bai gene clusters in c-25, and were also reported to be essential for 7α-dehydroxylation [14]. In addition, baiB is the first gene to be transcribed in the bai operon of C. scindens while baiH is the second-to-last, providing comprehensive coverage of the entire bai operon.
The results of qRT-PCR showed that, in the presence of CA, bai gene expression in G10 increased by a factor of 67.3, 29.8, and 16.6 for baiB, baiCD, and baiH, respectively (Figure 8a and Table S5). In c-25, expression of these genes increased by a factor of 218.8, 291.8, and 13.9 (Figure 8b and Table S6), suggesting that the predicted bai gene orthologues in c-25 are functional bai genes. However, there is a considerable difference in gene expression between bai genes in c-25, with baiB and baiCD expressed at levels about 15–20 times higher than baiH. In G10, bai gene expression levels were relatively similar and decreased according to the downstream order in the operon, as expected.

3.6. Identification of Additional 7α-Dehydroxylating Bacteria

Finally, we searched for other bacteria that may possess a similar bai gene structure and arrangement as in c-25. Because Bai protein sequences in c-25 were found to be quite different from those of conventional DCA producers, a Microbial Protein BLAST search was conducted using BaiB from c-25. By screening isolated and sequenced species, three bacterial strains were found possessing genes with 74-77% similarity to c-25 BaiB: Sporofaciens musculi [62], Dorea sp. AF36-15AT [63], and Dorea sp. AM58-8 [63]. The presence of other bai genes was confirmed in each strain. The arrangement of bai genes in these three strains is almost identical to that of c-25 (Figure 7) except that in S. musculi, a transporter gene is additionally encoded at the downstream end of the baiA2-F operon, and the baiI gene is located just downstream of baiH. The baiG-like transporter found in c-25 was also found in these three new candidate strains in an analogous position (Figure 7).

4. Discussion

In this study, the morphology, growth, bile acid metabolism, and genomic information of unique but forgotten secondary bile acid producer Eubacterium sp. c-25 were clarified. The list of known intestinal DCA producers has long been limited to a handful of species, with few new isolates being identified over decades of research [19]. To add to this, current models of DCA formation are primarily based on data gathered from C. scindens studies. While human fecal isolate Eubacterium sp. c-25 has been known to produce DCA [21], the physiological and genomic data newly acquired in this study challenge the current understanding of DCA producers, revealing a unique morphology (Figure 2), dependency on specific pH conditions for optimal growth and 7α-dehydroxylation (Figure 3), and a novel bai gene arrangement that could represent an entirely unexplored genotype in DCA producers, as evident by its presence in the multiple, phylogenetically distant intestinal/fecal isolates: S. musculi, Dorea sp. AF36-15AT, and Dorea sp. AM58-8 (Figure 6 and Figure 7).
The filamentous morphology of c-25 has not been observed in other DCA producers. Images of C. scindens, P. hiranonis, and C. hylemonae show that they share a similar rod shape, but any visible end-to-end linkages are limited to two or three-cell chains [18,28,64,65]. The filamentous morphology can be observed in various intestinal bacteria, including species of Lactobacillus and Bifidobacterium [66,67], but there are few, if any, reports of filamentous Clostridium species, as they are predominantly unlinked [66]. This further supports our findings that c-25 is phylogenetically distinct from known DCA producers.
Taxonomically, c-25 appears to be a member of the order Eubacteriales as suggested by the results of 16S rDNA-based phylogenetic analysis (Figure 5). However, due to the questionable taxonomic designation of its closest relative L. phocaeense, it is difficult to correctly classify c-25 in the current classification scheme of Lachnoclostridium [59].
As observed in Figure 3, growth and DCA production of all tested strains, including c-25, were considerably dependent on the medium pH. The idea of a pH range conducive for in vitro growth and 7α-dehydroxylation may hint at certain colonization preferences in the gastrointestinal environment. C. scindens appears to be able to proliferate at a relatively wide range of pH conditions, while c-25 may be limited to neutral or slightly alkaline environments. It is possible that the narrow pH range conducive to c-25 growth limits growth of this strain to specific individuals or sections of the gastrointestinal tract exhibiting higher pH. For instance, though results and test methods differed between studies, there seems to be a general consensus that the proximal colon pH ranges from about 5.8–6.7 and rises to 6.1–7.5 in the distal colon and rectum [50]. Gastrointestinal pH increases were also noted in patients with Crohn’s disease and ulcerative colitis [68]. Although the prevalence of c-25 in the human gut is unknown, it is possible that the strain occupies a specific niche such as the distal colon, or is present in higher numbers in irregular physiological conditions causing increased intestinal pH, suggesting that pH can potentially be used as a marker for disease states associated with increased DCA production. Recently, while the link between physiological pH and colonization was not specifically investigated, studies on location-specific colonization of inoculated C. scindens in gnotobiotic mouse models were conducted using nanoscale secondary ion mass spectrometry and meta-proteomic analyses [69,70]. The introduction of such advanced technologies and studies specifically tailored to account for the variation in gut pH by location and individual [49,51] are necessary to further investigate the ecological niches of c-25 and other DCA producers.
The requirement for 7α-dehydroxylation has long been the induction of the baiA2-I gene cluster, controlled by a single promoter and producing a single polycistronic mRNA [60,61]. While a recently published analysis of metagenome-assembled genomes has identified candidate DCA producers possessing various arrangements of the bai gene cluster deviating from the arrangement found in C. scindens [17], no strains had yet been experimentally proven to produce DCA. The discovery of the uniquely arranged but apparently functional bai gene cluster in c-25 and its presence in other bacterial species necessitates a re-examination of DCA producer diversity and the genetic basis for 7α-dehydroxylation. As shown in Figure 8, c-25 displayed considerably increased expression of baiB and baiCD in the presence of CA. In contrast, the CA-induced increase in baiH expression was modest. This disproportionate induction is consistent with the fact that c-25 bai genes are divided into multiple, separately transcribed gene clusters, but raises the question of how bai gene expression is both coordinated and regulated in c-25. The physiological and metabolic impact of these highly expressed bai genes requires further study, which may yield insights into the factors that influence DCA formation in the gastrointestinal environment.
The comparative analysis of bai genes in c-25 and C. scindens led to several questions regarding their function and conservation. First, although we hypothesize that the BaiG-like protein is a functional homologue of the bile acid transporter BaiG [71], this has yet to be confirmed experimentally. As it shares only 22% amino acid sequence identity with the BaiG protein in C. scindens, there are likely to be considerable differences in protein structure and biological functionality. Secondly, baiI, thought to encode a 7β-dehydratase [3] involved in the 7β-dehydroxylation of ursocholic acid (epimer of CA possessing a 7β-hydroxy group) to DCA, is found within the bai operon in previously analyzed DCA producers, but this gene is not co-localized with other bai genes in c-25 or the two Dorea species that share the same bai gene arrangement as c-25. As baiI has actually been shown to be unnecessary for 7α-dehydroxylation in vitro [14], there is a possibility that baiI is differentially expressed in c-25 and the two Dorea species only when substrates possessing the 7β-hydroxy group are available. Thirdly, in contrast to the other bai genes, baiH in c-25 showed high similarity to baiH from C. scindens (Figure 6), suggesting that it has an essential role in 7α-dehydroxylation and is an unsubstitutable protein. As noted in a recent study, protein sequences of baiH and its homologue baiCD appear to be more highly conserved than the other bai genes among homologues identified in metagenomic datasets [72], though baiCD sequence identity was not considerably high for c-25 in this case. As for the rest of the bai genes in c-25, all exhibited surprisingly low protein sequence similarity, with percent identity at ~50% (Figure 6). Due to the complexity of biochemical modifications required at each step of the 7α-dehydroxylation enzyme cascade [14], we expected a higher degree of bai gene conservation among DCA producers. However, the low protein similarity observed between c-25 and C. scindens, along with varying levels of differential expression presumably resulting from different gene arrangements, suggest that there may be more genotypic variability among DCA producers than previously expected.
The observation that the unique arrangement of bai genes found in Eubacterium sp. c-25 were found in other bacteria (i.e., S. musculis and Dorea spp.) is strong evidence for the existence of alternative bai genotypes in intestinal DCA producers. Large-scale metagenomic analyses suggest that bai genes are much more common in intestinal microbial communities than previously believed [17,72], calling into question the actual numbers and diversity of DCA producers beyond the few identified thus far [15,19].

5. Conclusions

The physiological and comparative genomic analyses of Eubacterium sp. c-25 conducted in this study demonstrate that this strain is not a typical DCA producer when compared to known DCA producers. Further investigation, including functional analysis of predicted bai genes and quantification of c-25 and other strains sharing similarly organized bai genes in gut microbial populations, can reveal the extent to which these strains contribute to DCA formation in the human intestines. Understanding the factors that drive DCA production is essential for understanding gastrointestinal health in a biomedical context due to DCA’s connection to diseases such as liver and colon cancer [6,7,8,9] and cholesterol gallstone disease [10,11]. As an example, dietary prebiotic supplementation has been shown to decrease cecal DCA levels in rats [73], suggesting that a similar approach may be beneficial in treating humans exhibiting disease states correlated with abnormal DCA levels. However, the development of such treatments and their safe application to humans requires a thorough understanding of bile acid metabolism, key DCA producers, and host-microbe interplay. This study provides novel insights into these areas in the hopes of elucidating the holistic role of DCA producers in the human gut and their impact on gastrointestinal health.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/microorganisms9112254/s1, Table S1: bai gene identifiers by locus tag, Table S2: qRT-PCR primer sequences, Table S3: Initial and final medium pH in Eubacterium sp. c-25, C. scindens G10, and C. scindens ATCC 35704T cultures, Table S4: Predicted bai gene promoter regions, Table S5: C. scindens G10 bai gene qRT-PCR data, Table S6: Eubacterium sp. c-25 bai gene qRT-PCR data, Supplementary File S1: OrthoFinder raw data.

Author Contributions

Conceptualization, S.F., T.H. and A.Y.; data curation, Y.G. and Y.O.; formal analysis, I.S. and Y.G.; investigation, I.S., Y.G., Y.O. and S.F.; project administration, S.F. and A.Y.; resources, S.F., T.H. and A.Y.; supervision, S.F. and A.Y.; visualization, I.S.; writing—original draft, I.S.; writing—review and editing, I.S., S.F., T.H. and A.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partly supported by the Project of Junior Scientist Promotion at Hokkaido University.

Data Availability Statement

Whole-genome sequences of Eubacterium sp. c-25 and Clostridium scindens G10 are publically available in the Genbank/EMBL/DDBJ database under the accession numbers AP024845 and AP024846, respectively.

Acknowledgments

We would like to thank Hiroshi Oda, Department of Bacteriology, Faculty of Medicine, Kagoshima University, for providing us with Eubacterium sp. c-25. We would also like to thank the members of the Electron Microscope Laboratory, Research Faculty of Agriculture, Hokkaido University, for technical assistance in preparing the materials and taking scanning electron microscope images.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hofmann, A.F. Chemistry and Enterohepatic Circulation of Bile Acids. Hepatology 1984, 4, 4S–14S. [Google Scholar] [CrossRef] [PubMed]
  2. Ridlon, J.M.; Harris, S.C.; Bhowmik, S.; Kang, D.J.; Hylemon, P.B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016, 7, 22–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Ridlon, J.M.; Kang, D.J.; Hylemon, P.B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 2006, 47, 241–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Hamilton, J.P.; Xie, G.; Raufman, J.P.; Hogan, S.; Griffin, T.L.; Packard, C.A.; Chatfield, D.A.; Hagey, L.R.; Steinbach, J.H.; Hofmann, A.F. Human cecal bile acids: Concentration and spectrum. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293, G256–G263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Aldini, R.; Roda, A.; Montagnani, M.; Cerrè, C.; Pellicciari, R.; Roda, E. Relationship between structure and intestinal absorption of bile acids with a steroid or side-chain modification. Steroids 1996, 61, 590–597. [Google Scholar] [CrossRef]
  6. Kitazawa, S.; Denda, A.; Tsutsumi, M.; Tsujiuchi, T.; Hasegawa, K.; Tamura, K.; Maruyama, H.; Konishi, Y. Enhanced preneoplastic liver lesion development under ‘selection pressure’ conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis 1989, 11, 1323–1328. [Google Scholar] [CrossRef]
  7. Yoshimoto, S.; Loo, T.M.; Atarashi, K.; Kanda, H.; Sato, S.; Oyadomari, S.; Iwakura, Y.; Oshima, K.; Morita, H.; Hattori, M.; et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499, 97–101. [Google Scholar] [CrossRef]
  8. McGarr, S.E.; Ridlon, J.M.; Hylemon, P.B. Diet, Anaerobic Bacterial Metabolism, and Colon Cancer: A Review of the Literature. J. Clin. Gastroenterol. 2005, 39, 98–109. [Google Scholar]
  9. Cao, H.; Xu, M.; Dong, W.; Deng, B.; Wang, S.; Zhang, Y.; Wang, S.; Luo, S.; Wang, W.; Qi, Y.; et al. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int. J. Cancer 2017, 140, 2545–2556. [Google Scholar] [CrossRef] [Green Version]
  10. Berr, F.; Kullak-Ublick, G.A.; Paumgartner, G.; Münzing, W.; Hylemon, P.B. 7α-Dehydroxylating Bacteria Enhance Deoxycholic Acid Input and Cholesterol Saturation of Bile in Patients With Gallstones. Gastroenterology 1996, 111, 1611–1620. [Google Scholar] [CrossRef]
  11. Wells, J.E.; Berr, F.; Thomas, L.A.; Dowling, R.H.; Hylemon, P.B. Isolation and characterization of cholic acid 7α-dehydroxylating fecal bacteria from cholesterol gallstone patients. J. Hepatol. 2000, 32, 4–10. [Google Scholar] [CrossRef]
  12. Buffie, C.G.; Bucci, V.; Stein, R.R.; McKenney, P.T.; Ling, L.; Gobourne, A.; No, D.; Liu, H.; Kinnebrew, M.; Viale, A.; et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015, 517, 205–208. [Google Scholar] [CrossRef] [Green Version]
  13. Lin, R.; Zhan, M.; Yang, L.; Wang, H.; Shen, H.; Huang, S.; Huang, X.; Xu, S.; Zhang, Z.; Li, W.; et al. Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation. Oncogene 2020, 39, 4983–5000. [Google Scholar] [CrossRef] [PubMed]
  14. Funabashi, M.; Grove, T.L.; Wang, M.; Varma, Y.; McFadden, M.E.; Brown, L.C.; Guo, C.; Higginbottom, S.; Almo, S.C.; Fischbach, M.A. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 2020, 582, 566–570. [Google Scholar] [CrossRef]
  15. Streidl, T.; Karkossa, I.; Segura Muñoz, R.R.; Eberl, C.; Zaufel, A.; Plagge, J.; Schmaltz, R.; Schubert, K.; Basic, M.; Schneider, K.M.; et al. The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice. Gut Microbes 2021, 13, e1854008. [Google Scholar] [CrossRef]
  16. Rath, S.; Rud, T.; Karch, A.; Pieper, D.H.; Vital, M. Pathogenic functions of host microbiota. Microbiome 2018, 6, 174. [Google Scholar] [CrossRef]
  17. Vital, M.; Rud, T.; Rath, S.; Pieper, D.H.; Schlüter, D. Diversity of Bacteria Exhibiting Bile Acid-inducible 7α-dehydroxylation Genes in the Human Gut. Comput. Struct. Biotechnol. J. 2019, 17, 1016–1019. [Google Scholar] [CrossRef]
  18. Kitahara, M.; Takamine, F.; Imamura, T.; Benno, Y. Assignment of Eubacterium sp. VPI 12708 and related strains with high bile acid 7α-dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 2000, 50, 971–978. [Google Scholar] [CrossRef] [PubMed]
  19. Doerner, K.C.; Takamine, F.; LaVoie, C.P.; Mallonee, D.H.; Hylemon, P.B. Assessment of Fecal Bacteria with Bile Acid 7α-Dehydroxylating Activity for the Presence of bai-Like Genes. Appl. Environ. Microbiol. 1997, 63, 1185–1188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Kitahara, M.; Sakata, S.; Sakamoto, M.; Benno, Y. Comparison among Fecal Secondary Bile Acid Levels, Fecal Microbiota and Clostridium scindens Cell Numbers in Japanese. Microbiol. Immunol. 2004, 48, 367–375. [Google Scholar] [CrossRef]
  21. Hirano, S.; Nakama, R.; Tamaki, M.; Masuda, N.; Oda, H. Isolation and Characterization of Thirteen Intestinal Microorganisms Capable of 7α-Dehydroxylating Bile Acids. Appl. Environ. Microbiol. 1981, 41, 737–745. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Masuda, N.; Oda, H.; Hirano, S.; Masuda, M.; Tanaka, H. 7α-Dehydroxylation of Bile Acids by Resting Cells of a Eubacterium lentum-Like Intestinal Anaerobe, Strain c-25. Appl. Environ. Microbiol. 1984, 47, 735–739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Masuda, N.; Oda, H.; Hirano, S.; Tanaka, H. Enhancement of the 7α-Dehydroxylase Activity of a Gram-Positive Intestinal Anaerobe by Flavins. Appl. Environ. Microbiol. 1983, 45, 308–309. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Takamine, F.; Imamura, T. 7β-Dehydroxylation of 3,7-Dihydroxy Bile Acids by a Eubacterium Species Strain C-25 and Stimulation of 7β-Dehydroxylation by Bacteroides distasonis Strain K-5. Microbiol. Immunol. 1985, 29, 1247–1252. [Google Scholar] [CrossRef]
  25. Hirano, S.; Masuda, N. Enhancement of the 7α-dehydroxylase activity of a gram-positive intestinal anaerobe by Bacteroides and its significance in the 7-dehydroxylation of ursodeoxycholic acid. J. Lipid Res. 1982, 23, 1152–1158. [Google Scholar] [CrossRef]
  26. Devendran, S.; Shrestha, R.; Alves, J.M.P.; Wolf, P.G.; Ly, L.; Hernandez, A.G.; Méndez-García, C.; Inboden, A.; Wiley, J.; Paul, O.; et al. Clostridium scindens ATCC 35704: Integration of Nutritional Requirements, the Complete Genome Sequence, and Global Transcriptional Responses to Bile Acids. Appl. Environ. Microbiol. 2019, 85, e00052-19. [Google Scholar] [CrossRef] [Green Version]
  27. Ridlon, J.M.; Hylemon, P.B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium. J. Lipid Res. 2012, 53, 66–76. [Google Scholar] [CrossRef] [Green Version]
  28. Morris, G.N.; Winter, J.; Cato, E.P.; Ritchie, A.E.; Bokkenheuser, V.D. Clostridium scindens sp. nov., a Human Intestinal Bacterium with Desmolytic Activity on Corticoids. Int. J. Syst. Bacteriol. 1985, 35, 478–481. [Google Scholar] [CrossRef] [Green Version]
  29. Tawthep, S.; Fukiya, S.; Lee, J.Y.; Hagio, M.; Ogura, Y.; Hayashi, T.; Yokota, A. Isolation of six novel 7-oxo- or urso-type secondary bile acid-producing bacteria from rat cecal contents. J. Biosci. Bioeng. 2017, 124, 514–522. [Google Scholar] [CrossRef]
  30. Kurdi, P.; Tanaka, H.; van Veen, H.W.; Asano, K.; Tomita, F.; Yokota, A. Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria. Microbiology 2003, 149, 2031–2037. [Google Scholar] [CrossRef] [Green Version]
  31. Hagio, M.; Matsumoto, M.; Fukushima, M.; Hara, H.; Ishizuka, S. Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. J. Lipid Res. 2009, 50, 173–180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Hirayama, Y.; Sakanaka, M.; Fukuma, H.; Murayama, H.; Kano, Y.; Fukiya, S.; Yokota, A. Development of a Double-Crossover Markerless Gene Deletion System in Bifidobacterium longum: Functional Analysis of the α-Galactosidase Gene for Raffinose Assimilation. Appl. Environ. Microbiol. 2012, 78, 4984–4994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Wick, R.R.; Judd, L.M.; Gorrie, C.L.; Holt, K.E. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 2017, 13, e1005595. [Google Scholar] [CrossRef] [Green Version]
  34. Wick, R.R.; Judd, L.M.; Gorrie, C.L.; Holt, K.E. Completing bacterial genome assemblies with multiplex MinION sequencing. Microb. Genom. 2017, 3, e000132. [Google Scholar] [CrossRef] [PubMed]
  35. Tanizawa, Y.; Fujisawa, T.; Nakamura, Y. DFAST: A flexible prokaryotic genome annotation pipeline for faster genome publication. Bioinformatics 2018, 34, 1037–1039. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Hyatt, D.; Chen, G.L.; LoCascio, P.F.; Land, M.L.; Larimer, F.W.; Hauser, L.J. Prodigal: Prokaryotic gene recognition and translation initiation site identification. BMC Bioinform. 2010, 11, 119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Thompson, J.D.; Higgins, D.G.; Gibson, T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680. [Google Scholar] [CrossRef] [Green Version]
  38. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef]
  39. Tamura, K.; Nei, M. Estimation of the Number of Nucleotide Substitutions in the Control Region of Mitochondrial DNA in Humans and Chimpanzees. Mol. Biol. Evol. 1993, 10, 512–526. [Google Scholar] [CrossRef]
  40. Lee, I.; Kim, Y.O.; Park, S.C.; Chun, J. OrthoANI: An improved algorithm and software for calculating average nucleotide identity. Int. J. Syst. Evol. Microbiol. 2016, 66, 1100–1103. [Google Scholar] [CrossRef]
  41. Emms, D.M.; Kelly, S. OrthoFinder: Solving fundamental biases in whole genome comparisons dramatically improves orthogroup inference accuracy. Genome Biol. 2015, 16, 157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Emms, D.M.; Kelly, S. OrthoFinder: Phylogenetic orthology inference for comparative genomics. Genome Biol. 2019, 20, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Carver, T.; Harris, S.R.; Berriman, M.; Parkhill, J.; McQuillan, J.A. Artemis: An integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics 2012, 28, 464–469. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Solovyev, V.; Salamov, A. Automatic Annotation of Microbial Genomes and Metagenomic Sequences. In Metagenomics and Its Applications in Agriculture, Biomedicine and Environmental Studies; Li, R.W., Ed.; Nova Science Publishers: Hauppauge, NY, USA, 2011; pp. 61–78. [Google Scholar]
  45. Pascal Andreu, V.; Roel-Touris, J.; Dodd, D.; Fischbach, M.A.; Medema, M.H. The gutSMASH web server: Automated identification of primary metabolic gene clusters from the gut microbiota. Nucleic Acids Res. 2021, 49, W263–W270. [Google Scholar] [CrossRef]
  46. Ye, J.; Coulouris, G.; Zaretskaya, I.; Cutcutache, I.; Rozen, S.; Madden, T.L. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012, 13, 134. [Google Scholar] [CrossRef] [Green Version]
  47. Sakanaka, M.; Nakakawaji, S.; Nakajima, S.; Fukiya, S.; Abe, A.; Saburi, W.; Mori, H.; Yokota, A. A Transposon Mutagenesis System for Bifidobacterium longum subsp. longum Based on an IS3 Family Insertion Sequence, ISBlo11. Appl. Environ. Microbiol. 2018, 84, e00824-18. [Google Scholar] [CrossRef] [Green Version]
  48. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021. [Google Scholar]
  49. Evans, D.F.; Pye, G.; Bramley, R.; Clark, A.G.; Dyson, T.J.; Hardcastle, J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988, 29, 1035–1041. [Google Scholar] [CrossRef] [Green Version]
  50. Fleming, I.; Defazio, J.; Zaborina, O.; Alverdy, J.C. Critical Illness and the Intestinal Microflora: pH as a Surrogate Marker. In Diet and Nutrition in Critical Care; Rajendram, R., Preedy, V.R., Patel, V.B., Eds.; Springer: New York, NY, USA, 2014; pp. 1–9. [Google Scholar] [CrossRef]
  51. Koziolek, M.; Grimm, M.; Becker, D.; Iordanov, V.; Zou, H.; Shimizu, J.; Wanke, C.; Garbacz, G.; Weitschies, W. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System. J. Pharm. Sci. 2015, 104, 2855–2863. [Google Scholar] [CrossRef]
  52. Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem. J. 2017, 474, 1823–1836. [Google Scholar] [CrossRef]
  53. Hylemon, P.B.; Cacciapuoti, A.F.; White, B.A.; Whitehead, T.R.; Fricke, R.J. 7α-Dehydroxylation of cholic acid by cell extracts of Eubacterium species V.P.I. 12708. Am. J. Clin. Nutr. 1980, 33, 2507–2510. [Google Scholar] [CrossRef] [Green Version]
  54. Brahimi, S.; Cadoret, F.; Fournier, P.E.; Moal, V.; Raoult, D. ‘Lachnoclostridium urinimassiliense’ sp. nov. and ‘Lachnoclostridium phocaeense’ sp. nov., two new bacterial species isolated from human urine after kidney transplantation. New Microbes New Infect. 2017, 16, 73–75. [Google Scholar] [CrossRef]
  55. Stackebrandt, E.; Ebers, J. Taxonomic parameters revisited: Tarnished gold standards. Microbiol. Today 2006, 33, 152–155. [Google Scholar]
  56. Kim, M.; Oh, H.S.; Park, S.C.; Chun, J. Towards a taxonomic coherence between average nucleotide identity and 16S rRNA gene sequence similarity for species demarcation of prokaryotes. Int. J. Syst. Evol. Microbiol. 2014, 64, 346–351. [Google Scholar] [CrossRef]
  57. Goris, J.; Konstantinidis, K.T.; Klappenbach, J.A.; Coenye, T.; Vandamme, P.; Tiedje, J.M. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int. J. Syst. Evol. Microbiol. 2007, 57, 81–91. [Google Scholar] [CrossRef] [Green Version]
  58. Jain, C.; Rodriguez-R, L.M.; Phillippy, A.M.; Konstantinidis, K.T.; Aluru, S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat. Commun. 2018, 9, 5114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Yutin, N.; Galperin, M.Y. A genomic update on clostridial phylogeny: Gram-negative spore formers and other misplaced clostridia. Environ. Microbiol. 2013, 15, 2631–2641. [Google Scholar] [CrossRef] [PubMed]
  60. Mallonee, D.H.; White, W.B.; Hylemon, P.B. Cloning and Sequencing of a Bile Acid-Inducible Operon from Eubacterium sp. Strain VPI 12708. J. Bacteriol. 1990, 172, 7011–7019. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Wells, J.E.; Hylemon, P.B. Identification and Characterization of a Bile Acid 7α-Dehydroxylation Operon in Clostridium sp. Strain TO-931, a Highly Active 7α-Dehydroxylating Strain Isolated from Human Feces. Appl. Environ. Microbiol. 2000, 66, 1107–1113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Rasmussen, T.S.; Streidl, T.; Hitch, T.C.A.; Wortmann, E.; Deptula, P.; Kofoed, M.V.W.; Riedel, T.; Neumann-Schaal, M.; Hansen, M.; Nielsen, D.S.; et al. Sporofaciens musculi gen. nov., sp. nov., a novel bacterium isolated from the caecum of an obese mouse. Int. J. Syst. Evol. Microbiol. 2021, 71, 004673. [Google Scholar] [CrossRef]
  63. Zou, Y.; Xue, W.; Luo, G.; Deng, Z.; Qin, P.; Guo, R.; Sun, H.; Xia, Y.; Liang, S.; Dai, Y.; et al. 1520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat. Biotechnol. 2019, 37, 179–185. [Google Scholar] [CrossRef]
  64. Kitahara, M.; Takamine, F.; Imamura, T.; Benno, Y. Clostridium hiranonis sp. nov., a human intestinal bacterium with bile acid 7α-dehydroxylating activity. Int. J. Syst. Evol. Microbiol. 2001, 51, 39–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Chen, X.J.; Wang, Z.Q.; Zhou, Z.Y.; Zeng, N.Y.; Huang, Q.F.; Wang, Z.W.; Tang, W.L.; Zhou, H.W. Characterization of Peptacetobacter hominis gen. nov., sp. nov., isolated from human faeces, and proposal for the reclassification of Clostridium hiranonis within the genus Peptacetobacter. Int. J. Syst. Evol. Microbiol. 2020, 70, 2988–2997. [Google Scholar] [CrossRef]
  66. de Vos, P.; Garrity, G.M.; Jones, D.; Krieg, N.R.; Ludwig, W.; Rainey, F.A.; Schleifer, K.H.; Whitman, W.B. Bergey’s Manual of Systematic Bacteriology: Volume 3: The Firmicutes, 2nd ed.; Springer: New York, NY, USA, 2009. [Google Scholar]
  67. Goodfellow, M.; Kämpfer, P.; Busse, H.J.; Trujillo, M.E.; Suzuki, K.; Ludwig, W.; Whitman, W.B. Bergey’s Manual of Systematic Bacteriology: Volume 5: The Actinobacteria, 2nd ed.; Springer: New York, NY, USA, 2012. [Google Scholar]
  68. Press, A.G.; Hauptmann, I.A.; Hauptmann, L.; Fuchs, B.; Fuchs, M.; Ewe, K.; Ramadori, G. Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 1998, 12, 673–678. [Google Scholar] [CrossRef]
  69. Marion, S.; Studer, N.; Desharnais, L.; Menin, L.; Escrig, S.; Meibom, A.; Hapfelmeier, S.; Bernier-Latmani, R. In vitro and in vivo characterization of Clostridium scindens bile acid transformations. Gut Microbes 2019, 10, 481–503. [Google Scholar] [CrossRef] [Green Version]
  70. Marion, S.; Desharnais, L.; Studer, N.; Dong, Y.; Notter, M.D.; Poudel, S.; Menin, L.; Janowczyk, A.; Hettich, R.L.; Hapfelmeier, S.; et al. Biogeography of microbial bile acid transformations along the murine gut. J. Lipid Res. 2020, 61, 1450–1463. [Google Scholar] [CrossRef]
  71. Mallonee, D.H.; Hylemon, P.B. Sequencing and Expression of a Gene Encoding a Bile Acid Transporter from Eubacterium sp. Strain VPI 12708. J. Bacteriol. 1996, 178, 7053–7058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Das, P.; Marcišauskas, S.; Ji, B.; Nielsen, J. Metagenomic analysis of bile salt biotransformation in the human gut microbiome. BMC Genomics 2019, 20, 517. [Google Scholar] [CrossRef] [Green Version]
  73. Lee, D.G.; Hori, S.; Kohmoto, O.; Kitta, S.; Yoshida, R.; Tanaka, Y.; Shimizu, H.; Takahashi, K.; Nagura, T.; Uchino, H.; et al. Ingestion of difructose anhydride III partially suppresses the deconjugation and 7α-dehydroxylation of bile acids in rats fed with a cholic acid-supplemented diet. Biosci. Biotechnol. Biochem. 2019, 83, 1329–1335. [Google Scholar] [CrossRef] [PubMed]
Microorganisms 09 02254 g001 550
Figure 1. Bai proteins and bai genes involved in the formation of DCA from CA. Overview of (a) the 7α-dehydroxylation of CA to DCA including Bai proteins and intermediate products in C. scindens VPI 12708, as proposed by Funabashi et al. [14], and (b) the arrangement of the bai operon in C. scindens VPI 12708 and ATCC 35704T [2]. Bai proteins are color coded with their respective genes in the bai operon. Figure created with BioRender.com.
Figure 1. Bai proteins and bai genes involved in the formation of DCA from CA. Overview of (a) the 7α-dehydroxylation of CA to DCA including Bai proteins and intermediate products in C. scindens VPI 12708, as proposed by Funabashi et al. [14], and (b) the arrangement of the bai operon in C. scindens VPI 12708 and ATCC 35704T [2]. Bai proteins are color coded with their respective genes in the bai operon. Figure created with BioRender.com.
Microorganisms 09 02254 g001
Microorganisms 09 02254 g002 550
Figure 2. Scanning electron micrographs of Eubacterium sp. c-25. Observed morphological states: (a) single-cell, (b,c) filamentous, and (d) entangled filaments. Visible extracellular structures are indicated by white arrows. Images shown were taken after 6 h (a,b,d) or 12 h (c) of growth.
Figure 2. Scanning electron micrographs of Eubacterium sp. c-25. Observed morphological states: (a) single-cell, (b,c) filamentous, and (d) entangled filaments. Visible extracellular structures are indicated by white arrows. Images shown were taken after 6 h (a,b,d) or 12 h (c) of growth.
Microorganisms 09 02254 g002
Microorganisms 09 02254 g003a 550Microorganisms 09 02254 g003b 550
Figure 3. Time-course analysis of the growth and bile acid profile of DCA producers including Eubacterium sp. c-25 under different initial pH conditions. Tested strains are: (a–d) C. scindens ATCC 35704T, (e–h) C. scindens G10, and (i–l) Eubacterium sp. c-25. Growth was measured by OD660 (dotted line). The percent composition is calculated by the concentration of a given bile acid relative to the summed concentration of CA (black square), DCA (red circle), and 7-oxo-DCA (blue triangle). The average values of three independent experiments are shown.
Figure 3. Time-course analysis of the growth and bile acid profile of DCA producers including Eubacterium sp. c-25 under different initial pH conditions. Tested strains are: (a–d) C. scindens ATCC 35704T, (e–h) C. scindens G10, and (i–l) Eubacterium sp. c-25. Growth was measured by OD660 (dotted line). The percent composition is calculated by the concentration of a given bile acid relative to the summed concentration of CA (black square), DCA (red circle), and 7-oxo-DCA (blue triangle). The average values of three independent experiments are shown.
Microorganisms 09 02254 g003aMicroorganisms 09 02254 g003b
Microorganisms 09 02254 g004 550
Figure 4. Heatmap of average nucleotide identity (ANI) values between Eubacterium sp. c-25, L. phocaeense, and other strains relevant to DCA production. Strains listed in Table 1 were used for ANI analysis. Heatmap was generated by OAT [40] and was reconstructed in high-resolution based on the original output.
Figure 4. Heatmap of average nucleotide identity (ANI) values between Eubacterium sp. c-25, L. phocaeense, and other strains relevant to DCA production. Strains listed in Table 1 were used for ANI analysis. Heatmap was generated by OAT [40] and was reconstructed in high-resolution based on the original output.
Microorganisms 09 02254 g004
Microorganisms 09 02254 g005 550
Figure 5. Maximum Likelihood phylogenetic tree of Eubacterium sp. c-25 and related species of the intestinal bacteria including known DCA producers. Strains included in the tree construction consisted of the 29 closest 16S rDNA sequence BLASTn matches to Eubacterium sp. c-25, excluding uncultured and unidentified strains, and 10 other manually added strains: L. phocaeense Marseille-P3177, C. scindens G10, C. scindens ATCC 35704T, P. hiranonis DSM 13275, S. musculi WCA-9-b2, Dorea sp. AF36-15AT, Dorea sp. AM 58-8, Lachnoclostridium edouardi Marseille-P3397 (NZ_OESQ01000006), Lachnoclostridium pacaense Marseille-P3100 (NZ_LS999944), and Lachnoclostridium phytofermentans ISDg344 (NC_010001). The strains used in bioinformatics analyses in this study are bolded. The tree was constructed in MEGA X [38] using the Tamura–Nei model [39] with 1000 bootstraps and was rooted at the midpoint. Bootstrap support values are listed next to the branches.
Figure 5. Maximum Likelihood phylogenetic tree of Eubacterium sp. c-25 and related species of the intestinal bacteria including known DCA producers. Strains included in the tree construction consisted of the 29 closest 16S rDNA sequence BLASTn matches to Eubacterium sp. c-25, excluding uncultured and unidentified strains, and 10 other manually added strains: L. phocaeense Marseille-P3177, C. scindens G10, C. scindens ATCC 35704T, P. hiranonis DSM 13275, S. musculi WCA-9-b2, Dorea sp. AF36-15AT, Dorea sp. AM 58-8, Lachnoclostridium edouardi Marseille-P3397 (NZ_OESQ01000006), Lachnoclostridium pacaense Marseille-P3100 (NZ_LS999944), and Lachnoclostridium phytofermentans ISDg344 (NC_010001). The strains used in bioinformatics analyses in this study are bolded. The tree was constructed in MEGA X [38] using the Tamura–Nei model [39] with 1000 bootstraps and was rooted at the midpoint. Bootstrap support values are listed next to the branches.
Microorganisms 09 02254 g005
Microorganisms 09 02254 g006 550
Figure 6. Heatmap table of bai gene amino acid sequence identity among known and newly-identified, hypothesized DCA producers. The closest phylogenetic relative of c-25, L. phocaeense, was also included. The amino acid sequence identity (%) was evaluated by BLASTp analysis using (a) C. scindens ATCC 35704T and (b) Eubacterium sp. c-25 reference bai genes as queries. BLAST Expect values (E-values) are given in parentheses. Darker boxes indicate higher degrees of sequence identity. ND = Not detected. See Table S1 for bai gene identifier information.
Figure 6. Heatmap table of bai gene amino acid sequence identity among known and newly-identified, hypothesized DCA producers. The closest phylogenetic relative of c-25, L. phocaeense, was also included. The amino acid sequence identity (%) was evaluated by BLASTp analysis using (a) C. scindens ATCC 35704T and (b) Eubacterium sp. c-25 reference bai genes as queries. BLAST Expect values (E-values) are given in parentheses. Darker boxes indicate higher degrees of sequence identity. ND = Not detected. See Table S1 for bai gene identifier information.
Microorganisms 09 02254 g006
Microorganisms 09 02254 g007 550
Figure 7. bai gene arrangements as observed in C. scindens G10, Eubacterium sp. c-25, Dorea sp. AF36-15AT, Dorea sp. AM58-8, and S. musculi. Shared genes (or predicted functional homologues in the case of baiG) are color-coded. Figure created with BioRender.com.
Figure 7. bai gene arrangements as observed in C. scindens G10, Eubacterium sp. c-25, Dorea sp. AF36-15AT, Dorea sp. AM58-8, and S. musculi. Shared genes (or predicted functional homologues in the case of baiG) are color-coded. Figure created with BioRender.com.
Microorganisms 09 02254 g007
Microorganisms 09 02254 g008 550
Figure 8. qRT-PCR results showing expression of baiB, baiCD, and baiH genes with or without CA supplementation. Expression was measured in (a) C. scindens G10 (n = 3) and (b) Eubacterium sp. c-25 (n = 7). Cells were cultured in GAM adjusted to pH 8 in the presence (CA) or absence (Control) of 0.1 mM CA and collected for total RNA extraction at mid-exponential growth phase. Mean values of the expression levels of each gene relative to the reference housekeeping gene recA are indicated. Error bars denote standard error of the mean. p-values lower than 0.05 were considered significant and indicated using numbers of asterisks in the panel (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
Figure 8. qRT-PCR results showing expression of baiB, baiCD, and baiH genes with or without CA supplementation. Expression was measured in (a) C. scindens G10 (n = 3) and (b) Eubacterium sp. c-25 (n = 7). Cells were cultured in GAM adjusted to pH 8 in the presence (CA) or absence (Control) of 0.1 mM CA and collected for total RNA extraction at mid-exponential growth phase. Mean values of the expression levels of each gene relative to the reference housekeeping gene recA are indicated. Error bars denote standard error of the mean. p-values lower than 0.05 were considered significant and indicated using numbers of asterisks in the panel (*: p < 0.05, **: p < 0.01, ***: p < 0.001).
Microorganisms 09 02254 g008
Table
Table 1. Genome information of the strains used in bioinformatics analyses.
Table 1. Genome information of the strains used in bioinformatics analyses.
OrganismGenome Size (bp)DatabaseAccession No.Source
Eubacterium sp. c-253,042,110DDBJAP024845Human
Clostridium scindens G103,315,593DDBJAP024846Rat
Clostridium scindens ATCC 35704T3,658,040NCBI RefSeqNZ_CP036170Human
Clostridium hylemonae BSD2780061688st1_A63,793,913NCBI RefSeqNZ_SPFR01000000Human
Peptacetobacter hiranonis DSM 132752,521,899NCBI RefSeqNZ_CP036523Human
Lachnoclostridium phocaeense Marseille-P31773,500,754NCBI RefSeqNZ_LT635479Human
Sporofaciens musculi WCA-9-b25,763,728NCBI RefSeqNZ_WUQX01000000Mouse
Dorea sp. AF36-15AT2,953,222JGI IMG2840399886 1Human
Dorea sp. AM58-83,102,867JGI IMG2854065680 1Human
1 IMG taxon ID.
Table
Table 2. Complete sequenced genome information.
Table 2. Complete sequenced genome information.
Eubacterium sp. c-25C. scindens G10
Genome size (bp)3,042,1103,315,593
GC content (%)44.546.5
No. of CDSs28933292
Average Protein Length315.6297.7
Coding Ratio (%)90.088.7
No. of rRNAs812
No. of tRNAs5558
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Song, I.; Gotoh, Y.; Ogura, Y.; Hayashi, T.; Fukiya, S.; Yokota, A. Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota. Microorganisms 2021, 9, 2254. https://doi.org/10.3390/microorganisms9112254

AMA Style

Song I, Gotoh Y, Ogura Y, Hayashi T, Fukiya S, Yokota A. Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota. Microorganisms. 2021; 9(11):2254. https://doi.org/10.3390/microorganisms9112254

Chicago/Turabian Style

Song, Isaiah, Yasuhiro Gotoh, Yoshitoshi Ogura, Tetsuya Hayashi, Satoru Fukiya, and Atsushi Yokota. 2021. "Comparative Genomic and Physiological Analysis against Clostridium scindens Reveals Eubacterium sp. c-25 as an Atypical Deoxycholic Acid Producer of the Human Gut Microbiota" Microorganisms 9, no. 11: 2254. https://doi.org/10.3390/microorganisms9112254

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop